Our Team

Management team

HistoIndex CEO Gideon Ho
Gideon Ho PhD
Co-founder and Chief Executive Officer (CEO)
Learn More
HistoIndex CEO Gideon Ho

Dr Gideon HO

Co-founder & Chief Executive Officer (CEO)

An A*STAR National Science Scholar (Fellowship), Gideon has been involved in bio-imaging research, commercial development and corporate management. In 2010, Gideon co-founded HistoIndex as a spin-off from the Agency for Science, Technology and Research (A*STAR), to develop and commercialise the world’s first fully automated, quantitative, stain-free imaging system and gain a first-mover advantage in global healthcare markets. Under his direction as the CEO, the laser-based stain-free imaging system was successfully implemented in academic, clinical and pharmaceutical research in major universities, hospitals and contract reference facilities around the world.

Dean Tai PhD
Co-founder and Chief Scientific Officer (CSO)
Learn More

Dr Dean TAI

Co-founder & Chief Scientific Officer (CSO)

As the CSO of HistoIndex, Dean is responsible for the strategic product development and worldwide research collaboration. Together with his HistoIndex co-founder, Dr. Gideon Ho, Dean has successfully launched the company’s platform technology in multiple global clinical studies. He has established multi-centre clinical trials with key opinion leaders, and successfully coordinated clinical validation worldwide using HistoIndex’s proprietary imaging and analysis technology .

Paddy Liang COO
Chief Operating Officer (COO)
Learn More

Mr Paddy LIANG

Chief Operating Officer (COO)

Paddy oversees the strategic direction in the company’s global operations and leads the overall production and implementation of the platform technology. Since joining HistoIndex in 2013, Paddy has streamlined the manufacturing process, optimising the workflow across departments including Engineering, Supplier Management and Environment, Health and Safety (EHS). 

Teng Xiao PhD
Chief Technology Officer (CTO)
Learn More

Teng Xiao

Chief Technology Officer (CTO)

Teng Xiao received his Ph.D. in Computer Engineering from Nanyang Technological University, Singapore. Since joining HistoIndex in 2013, Teng Xiao has designed and developed core image processing and machine learning (ML) algorithms for the company’s proprietary software technology.

Yukti Choudhury PhD
Director, Clinical Development
Learn More

Yukti Choudhury

PhD

Director, Clinical Development

Yukti provides strategic oversight and leads implementation of HistoIndex’s proprietary platforms into clinical diagnostics and routine patient care. At HistoIndex, Yukti works closely with hospital labs to clinically validate and obtain reimbursement coverage for lab-developed tests developed on the company’s digital pathology platform. Previously, Yukti served as Chief Technology Officer and co-founder of Lucence Diagnostics, directing design and validation of ultra-sensitive oncology tests. She led teams to clinically deploy proprietary laboratory-developed tests and achieve CLIA certification and CAP accreditation for the labs. She holds a PhD in Molecular Biology from the National University of Singapore. With her blend of R&D excellence and commercialization experience, Yukti excels at advancing novel platforms like HistoIndex’s into clinical practice.

Elaine Chng PhD
Associate Director, Regulatory Affairs and Clinical Services
Learn More

Elaine Chng

PhD

Associate Director, Regulatory Affairs and Clinical Services

Elaine oversees wide-ranging applications of Histoindex’s proprietary AI-based digital pathology platform in clinical trials and studies. She works closely with key opinion leaders to advance validation and adoption of the company’s innovative tissue analysis solutions to advocate for the company’s AI-powered platforms utilisation in FDA trials. Elaine holds a PhD in Biological Chemistry from Nanyang Technological University. Her doctoral research investigated nanomaterial safety and applications. Combining scientific excellence with cross-functional leadership, Elaine excels at managing complex projects to deliver impactful outcomes.

Serene Lek Director
Associate Director, Translational Development & Partnerships
Learn More

Serene Lek

Associate Director, Translational Development & Partnerships

Serene leads strategic partnership initiatives at Histoindex by driving industry collaborations to incorporate HistoIndex’s technology in clinical trials and studies, across NASH and fibrotic diseases including oncology. Previously, Serene founded and led Clinnovate Health as CEO, a contract research and health innovation organization offering histopathology and genomic services with key focus in fibrosis and transplant assessment. Before founding Clinnovate Health, Serene had experience in venture capital and private equity in healthcare investment funds and portfolio management in oncology applications. She leverages her passion and prior extensive experience in medtech commercialization to establish impactful and high-value collaborations with clinicians and biopharmaceutical companies.

Board of Directors

David John Jeans CBE
Non-Executive Chairman
HistoIndex CEO Gideon Ho
Gideon Ho PhD
Co-founder and Group Chief Executive Officer (CEO)
Dean Tai PhD
Co-founder and Group Chief Scientific Officer (CSO)
Sim Giok Lak Director
Non-executive Director
Sim Kok Hwee
Non-Executive Director

Advisors

Stephen Harrison MD, FACP, FAASLD, COL (ret.)
Scientific Advisory Board, Chairman
Quentin Anstee MBBS, PhD, MRCP (UK)
Scientific Advisory Board, Member
Arun Sanyal MD
Scientific Advisory Board, Member
Wei Lai MD, PhD
Scientific Advisory Board, Member
Jacob George MBBS, FRACPm PhD, FAASLD
Scientific Advisory Board, Member
Nikolai Naoumov MD, PhD, FRCPath, FAASLD, FaoP
Strategic Advisor